- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03687411
An Ultrasound Guided Automated Spinal Landmark Identification System (uSINE)
Development of an Ultrasound Guided Automated Spinal Landmark Identification System (uSINE Study)
Neuraxial ultrasonography has been shown a safe and effective technique to enhance the overall success rate of lumbar puncture and reduce the number of injection attempts. However, the current blind palpation landmark technique is known to be highly inaccurate and may increase the risk of multiple insertion attempts, patient suffering and complication rates such as spinal cord injury. Various clinical studies have confirmed the effectiveness of ultrasound imaging compared with the traditional palpation method. However, none of the present system can achieve real-time guidance.
The overall aim of this proposal is to develop an ultrasound guided automated spinal landmark identification with real-time neuraxial needle insertion system (uSINE) to improve patient safety and efficacy of neuraxial procedure needle insertion success. This will be achieved in 4 phases of technology development and clinical trial phases. The investigators will recruit 20 subjects in a prospective cohort study to investigate the spinal needle first attempt success rate as a clinically relevant outcome. The secondary aim is to develop an automated spinal landmark identification algorithm using image processing to identify spinal landmarks in 50 obese patients. Third phase objective will be to obtain clinical data, and evaluation and annotation of the clinical data of spinal ultrasonography in 65 obese patients (BMI > 30kg/m2), whereas the fourth phase will measure the uSINE identification accuracy and first-attempt puncture success rate of uSINE in a clinical study of 65 obese patients (BMI > 30kg/m2).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a prospective cohort study to evaluate the efficacy and accuracy of ultrasound guided automated spinal landmark identification with real-time neuraxial needle insertion system (uSINE).
The subjects assume a seated position and the lower back is exposed. Ultrasound gel will be applied to the lower back lumbar spine and the investigator will place an ultrasound curved array probe around the sacral region. The graphical interface of the software, integrated with the wireless ultrasound probe and ultrasound machine, will inform the investigator when the software has positively identified the sacrum. The investigator will then move the probe in a steady vertical upward longitudinal direction until the L3/4 interspinous space is identified by the program. The ultrasound algorithm will identify the skin surface marking. The longitudinal section of the scan will be completed and the investigator will turn the probe 90 degrees clockwise around the probe center to the transverse view.
The transverse scan consists of minimal vertical movements by the investigator who will obtain images using the ultrasound probe. The software will signal when the correct identification of the ligamentum flavum is visualized. The scan sequence will be completed.
The first phase will involve 20 non-obese patients who are undergoing neuraxial anaesthesia or analgesia. The system is used prior and during needle insertion to provide real-time guidance for the anaesthetists. The neuraxial needle insertion is conducted manually by the anaesthetist as per routine practice.
In the second phase, 50 obese patients (body mass index more than 30) will be recruited to investigate and develop an "obesity" mode visualisation of the ultrasound guided automated spinal landmark identification. This will be to advance the technology to evaluate more difficult anatomy and more complex neuraxial needle insertion in future work plan. The patients' back will be scanned to obtain the images. The neuraxial needle insertion is conducted manually (i.e. independent of the ultrasound results) by the anaesthetist as per hospital routine practice.
The third phase involve data collection and annotation of spinal ultrasonography in 65 obese patients, followed by a fourth phase to measure the uSINE identification accuracy and first-attempt puncture success rate in 65 obese patients.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ban L Sng, FANZCA
- Phone Number: +6563941081
- Email: sng.ban.leong@singhealth.com.sg
Study Contact Backup
- Name: Alex T Sia, MMED
- Phone Number: +6563941081
- Email: alex.sia.t.h@singhealth.com.sg
Study Locations
-
-
-
Singapore, Singapore, 229899
- Recruiting
- KK Women's and Children's Hospital
-
Contact:
- Ban Leong Sng, MBBS, MMED
- Phone Number: +6563941081
- Email: sng.ban.leong@singhealth.com.sg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
First phase:
- Age 21 - 75 years old patients who require neuraxial anesthesia for surgical procedure;
- Normal body mass index (Weight 40-90 kg, Height 140-180cm).
Second-fourth phases:
- Obese patients aged between 21-75 years old;
- body mass index more than 30.
Exclusion Criteria:
- History of scoliosis;
- History of spinal instrumentation;
- Drug allergy to ultrasound transmission gel;
- Visible wound or injury in the lumbar spine.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: ULTRA-SINE (phases 1-4)
There will be four phases in this proposed uSINE system. In first phase attending anaesthetist will use the automated spinal landmark system for neuraxial needle insertion to place the neuraxial anaesthesia in non-obese patients. For the second phase, obese patients will have ultrasound scan of their lumbar back and no needle insertion is involved. In third phase, conventional ultrasonography is used prior to the needle insertion, and needle insertion is conducted manually as per routine practice. The images collected in the system will be used for annotation and evaluation which serves as training material for uSINE to optimize its algorithm to improve landmark identification for obese patients. The fourth phase will have uSINE system used prior to the needle insertion, with the neuraxial needle insertion conducted manually as per routine practice. The identification accuracy and first-attempt puncture success rate of uSINE will be determined. |
Ultrasound gel is applied to lower back lumbar spine of patient and placed with an ultrasound probe around the sacral region.
The graphical interface of the software integrated with ultrasound machine will help identify the sacrum.
The probe is moved in until the L3/4 interspinous space is identified for skin surface marking.
Once the longitudinal scan is completed, the investigator will turn the probe 90° clockwise for transverse scan to identify ligamentum flavum.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
First attempt success rate of spinal anaesthesia
Time Frame: 12 hours
|
The rate of cases achieving successful spinal anaesthesia at first attempt of insertion
|
12 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of spinal attempts
Time Frame: 12 hours
|
The number of attempts to achieve successful spinal anaesthesia
|
12 hours
|
|
Time taken for ligamentum flavum identification
Time Frame: 12 hours
|
Time taken to identify the ligamentum flavum in the transverse view
|
12 hours
|
|
Distance from skin to ligamentum flavum
Time Frame: 12 hours
|
Distance from skin to ligamentum flavum as detected by the algorithm
|
12 hours
|
Collaborators and Investigators
Investigators
- Principal Investigator: Ban L Sng, FANZCA, KK Women's and Children's Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- NHIC-I2D-1708180
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
Clinical Trials on Neuraxial ultrasonography
-
Mariah ArifCompleted
-
Nanjing Medical UniversityCompleted
-
Mariah ArifCompletedNeuraxial BlocksQatar
-
Dong-Xin WangShenzhen Maternity and Child Healthcare HospitalRecruitingPostpartum Depression | Labor Pain | Offspring, Adult | Maternal Anesthesia and Analgesia Affecting Fetus or Newborn | Neurodevelopmental DelayChina
-
Peking University First HospitalBeijing Haidian Maternal and Child Health Hospital; Beijing Obstetrics and...CompletedDepression, Postpartum | Parturition | Analgesia, Obstetrical
-
University of KentuckyCompleted
-
Augusta UniversityCompletedFetal BradycardiaUnited States
-
National Maternity Hospital, IrelandUnknownObesity | Neuraxial Ultrasound | Obstetric Anaesthesia
-
Guy's and St Thomas' NHS Foundation TrustRecruitingObstetric Anesthesia ProblemsUnited Kingdom
-
Benha UniversityUnknownPostmenopausal BleedingEgypt